Related Experiment Video
Updated: Aug 20, 2025

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
[Melanoma microenvironment-impact of modern therapies]
Judith Sirokay1, Cornelia Mauch2
1Klinik und Poliklinik für Dermatologie und Allergologie, Universitätsklinikum Bonn, Gebäude 11, Venusberg-Campus 1, 53127, Bonn, Deutschland. judith.sirokay@ukbonn.de.
Background:
A considerable proportion of patients with advanced melanoma succumb to metastatic disease despite the initial success of modern therapies.
Objectives:
An overview of the melanoma tumor microenvironment with special focus on approved therapies and new innovative strategies is given.
Methods:
Current clinical trials and scientific insights concerning the impact of the tumor microenvironment on progression and therapy of advanced melanoma are reviewed and discussed.
Results:
The tumor microenvironment with its manifold components and interactions plays a major role in the treatment of malignant melanoma.
Conclusion:
Innovative new strategies that target an immunosuppressive microenvironment may improve the therapeutic efficacy of current treatment of advanced melanoma.
Insights
Despite initial success, many advanced melanoma patients develop metastatic disease. Targeting the tumor microenvironment offers innovative strategies to improve melanoma treatment efficacy.
Area of Science:
- Oncology
- Immunology
- Dermatology
Context:
- Advanced melanoma presents a significant challenge due to metastatic progression.
- Current therapies show initial success but often fail to prevent disease spread.
Purpose:
- To provide an overview of the melanoma tumor microenvironment.
- To discuss approved therapies and novel strategies for advanced melanoma treatment.
Summary:
- The tumor microenvironment (TME) is crucial in melanoma progression and response to therapy.
- Components and interactions within the TME significantly influence treatment outcomes.
- Current research focuses on understanding these interactions to develop better therapeutic approaches.
Impact:
- Innovative strategies targeting an immunosuppressive TME hold promise for improving therapeutic efficacy.
- Modulating the tumor microenvironment could overcome resistance to existing melanoma treatments.
- This review aids in developing more effective treatment paradigms for advanced melanoma.
Related Concept Videos
The Tumor Microenvironment
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...

